These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3404240)

  • 21. Acute effects of nimodipine on the cerebral blood flow and intracranial pressure.
    Gaab MR; Haubitz I; Brawanski A; Korn A; Czech T
    Neurochirurgia (Stuttg); 1985 May; 28 Suppl 1():93-9. PubMed ID: 4010872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nimodipine reduces morbidity, mortality after disruption of cerebral blood flow.
    Carmody J; Lilly JK
    W V Med J; 1990 Feb; 86(2):49-51. PubMed ID: 2408232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of thromboxane synthase inhibition on eicosanoid levels and blood flow in ischemic rat brain.
    Pettigrew LC; Grotta JC; Rhoades HM; Wu KK
    Stroke; 1989 May; 20(5):627-32. PubMed ID: 2718203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostaglandin E1 reduces thromboxane A2 in hepatic ischemia-reperfusion.
    Hanazaki K; Kuroda T; Kajikawa S; Amano J
    Hepatogastroenterology; 2000; 47(33):807-11. PubMed ID: 10919036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Failure of flunarizine to improve cerebral blood flow or neurologic recovery in a canine model of complete cerebral ischemia.
    Newberg LA; Steen PA; Milde JH; Michenfelder JD
    Stroke; 1984; 15(4):666-71. PubMed ID: 6464059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nimodipine does not affect cerebral lactate levels following complete ischemia in dogs.
    Michenfelder JD; Milde JH
    J Cereb Blood Flow Metab; 1987 Oct; 7(5):619-24. PubMed ID: 3654802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thromboxane A2/prostaglandin H2 receptor activation mediates angiotensin II-induced postischemic neovascularization.
    Michel F; Silvestre JS; Waeckel L; Corda S; Verbeuren T; Vilaine JP; Clergue M; Duriez M; Levy BI
    Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):488-93. PubMed ID: 16385086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of nimodipine on intracellular brain pH, cortical blood flow, and EEG in experimental focal cerebral ischemia.
    Meyer FB; Anderson RE; Yaksh TL; Sundt TM
    J Neurosurg; 1986 Apr; 64(4):617-26. PubMed ID: 3950744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beagle pup model of perinatal asphyxia: nimodipine studies.
    Ment LR; Stewart WB; Duncan CC; Pitt BR
    Stroke; 1987; 18(3):599-605. PubMed ID: 3590252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of nimodipine on cerebral blood flow in human cerebral ischaemia.
    Pozzilli C; Di Piero V; Pantano P; Rasura M; Lenzi GL
    J Neurol; 1989 May; 236(4):199-202. PubMed ID: 2760631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of calcium antagonists on the cerebral circulation.
    Gelmers HJ
    Am J Cardiol; 1987 Jan; 59(3):173B-176B. PubMed ID: 2433932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nimodipine posttreatment does not increase blood flow in rats with focal cortical ischemia.
    Dirnagl U; Jacewicz M; Pulsinelli W
    Stroke; 1990 Sep; 21(9):1357-61. PubMed ID: 2204148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Failure of nimodipine to prevent ischemic neuronal damage in rats.
    Vibulsresth S; Dietrich WD; Busto R; Ginsberg MD
    Stroke; 1987; 18(1):210-6. PubMed ID: 3810755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of nimodipine on multiunit activity of several brain structures following acute global cerebral ischemia-anoxia in cats.
    Cervantes M; Chávez-Carrillo I; Antonio-Ocampo A
    Bol Estud Med Biol; 1992; 40(1-4):21-30. PubMed ID: 1296669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nimodipine attenuates both increase in cytosolic free calcium and histologic damage following focal cerebral ischemia and reperfusion in cats.
    Uematsu D; Greenberg JH; Hickey WF; Reivich M
    Stroke; 1989 Nov; 20(11):1531-7. PubMed ID: 2815188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparative study of dilceren (nimodipine) on the cerebral circulation in the intact animals and animals subjected to ischemic brain damage].
    Aleksandrin VV; Khaĭlov NA; Mirzoian GR; Gan'shina TS
    Eksp Klin Farmakol; 2002; 65(2):17-9. PubMed ID: 12109284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebrovascular effects of the calcium antagonistic dihydropyridine derivative nimodipine in animal experiments.
    Kazda S; Garthoff B; Krause HP; Schlossmann K
    Arzneimittelforschung; 1982; 32(4):331-8. PubMed ID: 7201801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo actions of a calcium channel blocker (nimodipine) on the cerebrovascular response to infused 5-hydroxytryptamine.
    McCalden TA; Tanahashi N; Nath RG; Coleman L; Meyer JS
    J Pharmacol Exp Ther; 1986 Apr; 237(1):36-9. PubMed ID: 3958972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The therapeutic value of nimodipine in experimental focal cerebral ischemia. Neurological outcome and histopathological findings.
    Germano IM; Bartkowski HM; Cassel ME; Pitts LH
    J Neurosurg; 1987 Jul; 67(1):81-7. PubMed ID: 3598674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nimodipine prevents hyperglycemia-induced cerebral acidosis in middle cerebral artery occluded rats.
    Berger L; Hakim AM
    J Cereb Blood Flow Metab; 1989 Feb; 9(1):58-64. PubMed ID: 2910898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.